321 related articles for article (PubMed ID: 36328679)
1. Prevention of Cervical Cancer in Low-Resource African Settings.
Mulongo M; Chibwesha CJ
Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
[TBL] [Abstract][Full Text] [Related]
2. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
3. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
[TBL] [Abstract][Full Text] [Related]
4. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
[TBL] [Abstract][Full Text] [Related]
5. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
[TBL] [Abstract][Full Text] [Related]
6. The next steps in cervical screening.
Sankaranarayanan R; Qiao YL; Keita N
Womens Health (Lond); 2015 Mar; 11(2):201-12. PubMed ID: 25776294
[TBL] [Abstract][Full Text] [Related]
7. [Human Papillomavirus: screening of cervical and anal cancers].
Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
[TBL] [Abstract][Full Text] [Related]
8. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
9. Preventing Cervical Cancer Globally: Are We Making Progress?
Allanson ER; Schmeler KM
Cancer Prev Res (Phila); 2021 Dec; 14(12):1055-1060. PubMed ID: 34853026
[TBL] [Abstract][Full Text] [Related]
10. Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic.
Smith DL; Perkins RB
Prev Med; 2022 Jun; 159():107070. PubMed ID: 35461955
[TBL] [Abstract][Full Text] [Related]
11. The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support.
Keane A; Ng CW; Simms KT; Nguyen D; Woo YL; Saville M; Canfell K
Int J Cancer; 2021 Dec; 149(12):1997-2009. PubMed ID: 34363620
[TBL] [Abstract][Full Text] [Related]
12. HPV Update: Vaccination, Screening, and Associated Disease.
McNamara M; Batur P; Walsh JME; Johnson KM
J Gen Intern Med; 2016 Nov; 31(11):1360-1366. PubMed ID: 27184752
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
14. HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia.
Davies P; Aluloski I; Arifdjanova D; Brcanski J; Davidzenka A; Durdyeva A; Gayrat Umarzoda S; Goshliyev K; Jovanovic V; Jugeli L; Kocinaj-Berisha M; Maistruk G; Naumovic T; Pilav A; Rzayeva G; Saribekyan K; Siljak S; Ten E; Valuta D; Veljkovic M; Yildirimkaya G; Ylli A; Zhylkaidarova A; Melnic E
Asian Pac J Cancer Prev; 2023 May; 24(5):1781-1788. PubMed ID: 37247301
[TBL] [Abstract][Full Text] [Related]
15. [Screening for cervical cancer, human papillomavirus (HPV) vaccination].
Schaff Z; Járay B
Magy Onkol; 2022 Dec; 66(4):325-330. PubMed ID: 37161827
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer prevention: Human papillomavirus testing as primary screening.
Desai S; Zhu MJ; Lapidos-Salaiz I
Cancer; 2022 Mar; 128(5):939-943. PubMed ID: 34767263
[TBL] [Abstract][Full Text] [Related]
19. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
20. A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention.
Nowakowski A; Arbyn M; Turkot MH; Wieszczy P; Miłosz K; Kamiński MF; Didkowska J; Bidziński M; Olszewski W; Wielgoś M; Krzakowski M; Kuchar E; Walewski J
Eur J Cancer Prev; 2020 Mar; 29(2):157-164. PubMed ID: 31517672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
